Are drug safety measures harmonized? A real-world data from three regulatory authorities

被引：0
|
作者：
Alelayan, Sadeem Fahad [1 ]
Al-Sheikh, Leena A.
Almutawa, Rana [2 ]
Alkofide, Hadeel [1 ]
Alshammari, Thamir M. [3 ]
机构：
[1] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia
[2] King Saud Univ, Coll Pharm, Riyadh, Saudi Arabia
[3] Saudi Food & Drug Author, Riyadh, Saudi Arabia
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1287
引用
收藏
页码：599 / 600
页数：2
相关论文
共 50 条
  • [41] Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness
    Mahendraratnam, Nirosha
    Mercon, Kerra
    Gill, Mira
    Benzing, Laura
    McClellan, Mark B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 150 - 154
  • [42] REAL-WORLD EFFICACY AND SAFETY OF SECUKINUMAB: DATA FROM VERONA'S COHORT
    Martinis, F.
    Caimmi, C.
    Carletto, A.
    Fracassi, E.
    Rossini, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1544 - 1545
  • [43] EFFICACY AND SAFETY OF BARICITINIB AND TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM REAL-WORLD
    Gonzalez Mazario, R.
    Fragio-Gil, J. J.
    Grau Garcia, E.
    De la Rubia Navarro, M.
    Pavez Perales, C.
    Leal Rodriguez, S.
    Ivorra Cortes, J.
    Negueroles Albuixech, R.
    Gonzalez Puig, L.
    Oller Rodriguez, J. E.
    Alcaniz Escandell, C.
    Vicens Bernabeu, E.
    Chalmeta Verdejo, I.
    Martinez Cordellat, I.
    Ortiz Sanjuan, F. M.
    Najera Herranz, C.
    Canovas Olmos, I.
    Canada Martinez, A. J.
    Roman Ivorra, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 639 - 640
  • [44] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [45] Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
    Chen, Jie
    Gruber, Susan
    Lee, Hana
    Chu, Haitao
    Lee, Shiowjen
    Tian, Haijun
    Wang, Yan
    He, Weili
    Jemielita, Thomas
    Song, Yang
    Tamura, Roy
    Tian, Lu
    Zhao, Yihua
    Chen, Yong
    van Der Laan, Mark
    Nie, Lei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (04) : 946 - 960
  • [46] The application of real-world evidence in drug regulatory decision-making
    Wicherski, Julia
    Haenisch, Britta
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2024, 67 (02) : 255 - 256
  • [47] Developing real-world evidence from real-world data: Transforming raw data into analytical datasets
    Bastarache, Lisa
    Brown, Jeffrey S.
    Cimino, James J.
    Dorr, David A.
    Embi, Peter J.
    Payne, Philip R. O.
    Wilcox, Adam B.
    Weiner, Mark G.
    LEARNING HEALTH SYSTEMS, 2022, 6 (01):
  • [48] Using Social Media as a Source of Real-World Data for Pharmaceutical Drug Development and Regulatory Decision Making
    Wessel, Didrik
    Pogrebnyakov, Nicolai
    DRUG SAFETY, 2024, 47 (05) : 495 - 511
  • [49] REAL-WORLD DATA
    STROCK, JM
    POLICY REVIEW, 1993, 63 : 96 - 96
  • [50] Real-world data of lung cancer: What about safety?
    Overbeek, Jetty A.
    Holthuis, Emily
    van den Heuvel, Michel
    Herings, Ron M. C.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 563 - 563
12345